The Wall Street Journal: J&J to end COVID vaccine manufacturing deal with Emergent Biosolutions
Johnson & Johnson said Monday it planned to terminate its COVID-19 vaccine supply deal with contract manufacturer Emergent BioSolutions Inc., as both companies accused each other of breaching the agreement.